BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
14
Active:12
Completed:2
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
28
FDA:28
Drug Approvals
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)No trials found
News
No news found